4-(tert-Butyl)phenylacetylene
| Title | Journal |
|---|---|
| Thr302 is the site for the covalent modification of human cytochrome P450 2B6 leading to mechanism-based inactivation by tert-butylphenylacetylene. | Drug metabolism and disposition: the biological fate of chemicals 20111201 |
| Structural analysis of mammalian cytochrome P450 2B4 covalently bound to the mechanism-based inactivator tert-butylphenylacetylene: insight into partial enzymatic activity. | Biochemistry 20110607 |
| Targeting of the highly conserved threonine 302 residue of cytochromes P450 2B family during mechanism-based inactivation by aryl acetylenes. | Archives of biochemistry and biophysics 20110301 |
| Covalent modification of Thr302 in cytochrome P450 2B1 by the mechanism-based inactivator 4-tert-butylphenylacetylene. | The Journal of pharmacology and experimental therapeutics 20100601 |
| Defining the structural consequences of mechanism-based inactivation of mammalian cytochrome P450 2B4 using resonance Raman spectroscopy. | Journal of the American Chemical Society 20100210 |
| Mechanism-based inactivation of CYP2B1 and its F-helix mutant by two tert-butyl acetylenic compounds: covalent modification of prosthetic heme versus apoprotein. | The Journal of pharmacology and experimental therapeutics 20091101 |
| tert-Butylphenylacetylene is a potent mechanism-based inactivator of cytochrome P450 2B4: inhibition of cytochrome P450 catalysis by steric hindrance. | Molecular pharmacology 20091101 |